← FDA DRUG APPROVALS

FDA ANDA · ANDA077656

THRIVE

Sponsor: GLAXOSMITHKLINE CONS

APPLICATION
ANDA077656
TYPE
ANDA
ORIGINAL APPROVAL
2007-06-19
LATEST ACTION
2007-06-19
ROUTE
BUCCAL
DOSAGE FORM
GUM, CHEWING
MARKETING STATUS
Discontinued

Products

THRIVEDiscontinued
NICOTINE POLACRILEX EQ 4MG BASE · GUM, CHEWING · BUCCAL

Approval history

2007-06-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →